Evidence map›Paper›PMID 41890360›Full record

ReviewNeuro-oncology advances

Tumor resection in glioblastoma mouse models: Surgical techniques and translational potential.

Julie Van Nieuwenhuyze, Aaron Ziani Zeryouh, Stéphanie De Vleeschauwer, Matteo Riva, An Coosemans

Abstract readReview
In one paragraph

Review in Neuro-oncology advances. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Julie Van NieuwenhuyzeLaboratory of Tumor Immunology and Immunotherapy, Department of Oncology, Leuven Cancer Institute, KU Leuven, Belgium.ORCID https://orcid.org/0009-0009-1389-4676
Aaron Ziani ZeryouhLaboratory of Tumor Immunology and Immunotherapy, Department of Oncology, Leuven Cancer Institute, KU Leuven, Belgium.ORCID https://orcid.org/0000-0002-6321-5311
Stéphanie De VleeschauwerLaboratory Animal Center KU Leuven, Leuven, Belgium.ORCID https://orcid.org/0009-0002-6392-537X
Matteo RivaLaboratory of Tumor Immunology and Immunotherapy, Department of Oncology, Leuven Cancer Institute, KU Leuven, Belgium.ORCID https://orcid.org/0000-0001-5962-5513
An CoosemansLaboratory of Tumor Immunology and Immunotherapy, Department of Oncology, Leuven Cancer Institute, KU Leuven, Belgium.ORCID https://orcid.org/0000-0002-7321-4339

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Surgical resection is a cornerstone of glioblastoma (GBM) treatment in patients; yet, it remains underrepresented in preclinical studies with mouse models. This narrative review analyzes the current resection techniques used in mouse GBM studies and evaluates their feasibility, reproducibility and translational relevance. A total of 27 eligible studies were included in the review and categorized by resection method: non-guided biopsy punch, non-guided freehand resection, fluorescence-guided freehand resection (using fluorescent cell lines or dyes), and magnetic resonance imaging (MRI)-guided approaches. While non-guided techniques (biopsy punch or freehand) are commonly employed due to their simplicity and affordability, they lack the precision and adaptability of more advanced methods. Fluorescence-guided resection improves tumor visualization but requires costly equipment and can introduce immunological biases. So-called MRI-guided strategies remain rare, and MRI is not actually used intraoperatively. Despite technically challenging, GBM surgical resection in mice is feasible and several effective techniques are currently available. The systematic implementation of tumor resection in GBM preclinical studies could allow to more closely mimic the human scenario thereby improving the predictive value of GBM animal experiments.

Identifiers

PMID41890360
PMCPMC13014170

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.